Global Multiple Myeloma Treatment Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 102
Published Date: 14 Sep 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
Description 
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags 
Description
According to our (Global Info Research) latest study, the global Multiple Myeloma Treatment Drugs market size was valued at US$ 3113 million in 2024 and is forecast to a readjusted size of USD 4680 million by 2031 with a CAGR of 6.0% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Multiple Myeloma Treatment Drugs
According to our (Global Info Research) latest study, the global Multiple Myeloma Treatment Drugs market size was valued at US$ 3113 million in 2024 and is forecast to a readjusted size of USD 4680 million by 2031 with a CAGR of 6.0% during review period.
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
Multiple Myeloma treatment drugs refer to therapeutic agents designed to intervene in and control the malignant proliferation of plasma cells, including immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), monoclonal antibodies, CAR-T cell therapies, bispecific antibodies, HDAC inhibitors, and emerging targeted therapies. At the upstream level of the value chain, manufacturing heavily relies on bioreactor culture media, recombinant cell lines, plasmid vectors for antibody production, cell culture reagents (FBS, serum-free media), buffers, chromatography resins, and single-use bioprocess consumables (such as disposable bags and filtration membranes). Key global suppliers include Thermo Fisher Scientific, Sartorius, Danaher (via Cytiva and Pall), Eppendorf, Merck KGaA (MilliporeSigma), and Lonza, which dominate the provision of raw materials and bioprocessing components, thereby determining the cost structure and quality assurance of Multiple Myeloma drug manufacturing. In 2024, the global sales of multiple myeloma treatment drugs amounted to 1.344 million doses, with an average price of $2,250 per dose.
This report is a detailed and comprehensive analysis for global Multiple Myeloma Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Multiple Myeloma Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Multiple Myeloma Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Multiple Myeloma Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Multiple Myeloma Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multiple Myeloma Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multiple Myeloma Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Takeda, Amgen, Sanofi, Merck, Johnson & Johnson, Novartis, AbbVie, Karyopharm Therapeutics, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Multiple Myeloma Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immunomodulatory drugs (IMiDs)
Proteasome inhibitors (PIs)
Monoclonal antibodies (mAbs)
Chimeric Antigen Receptor T-cell therapy (CAR-T therapy)
Histone deacetylase inhibitors (HDAC inhibitors)
Others
Market segment by Application
Hospital
Clinic
Major players covered
Bristol Myers Squibb
Takeda
Amgen
Sanofi
Merck
Johnson & Johnson
Novartis
AbbVie
Karyopharm Therapeutics
Teva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Multiple Myeloma Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Multiple Myeloma Treatment Drugs, with price, sales quantity, revenue, and global market share of Multiple Myeloma Treatment Drugs from 2020 to 2025.
Chapter 3, the Multiple Myeloma Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Multiple Myeloma Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Multiple Myeloma Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Multiple Myeloma Treatment Drugs.
Chapter 14 and 15, to describe Multiple Myeloma Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Multiple Myeloma Treatment Drugs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Immunomodulatory drugs (IMiDs)
1.3.3 Proteasome inhibitors (PIs)
1.3.4 Monoclonal antibodies (mAbs)
1.3.5 Chimeric Antigen Receptor T-cell therapy (CAR-T therapy)
1.3.6 Histone deacetylase inhibitors (HDAC inhibitors)
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Multiple Myeloma Treatment Drugs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Multiple Myeloma Treatment Drugs Market Size & Forecast
1.5.1 Global Multiple Myeloma Treatment Drugs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Multiple Myeloma Treatment Drugs Sales Quantity (2020-2031)
1.5.3 Global Multiple Myeloma Treatment Drugs Average Price (2020-2031)
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb Multiple Myeloma Treatment Drugs Product and Services
2.1.4 Bristol Myers Squibb Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bristol Myers Squibb Recent Developments/Updates
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Multiple Myeloma Treatment Drugs Product and Services
2.2.4 Takeda Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Takeda Recent Developments/Updates
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Multiple Myeloma Treatment Drugs Product and Services
2.3.4 Amgen Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Amgen Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Multiple Myeloma Treatment Drugs Product and Services
2.4.4 Sanofi Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sanofi Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Multiple Myeloma Treatment Drugs Product and Services
2.5.4 Merck Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Merck Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Multiple Myeloma Treatment Drugs Product and Services
2.6.4 Johnson & Johnson Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Multiple Myeloma Treatment Drugs Product and Services
2.7.4 Novartis Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Novartis Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Multiple Myeloma Treatment Drugs Product and Services
2.8.4 AbbVie Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AbbVie Recent Developments/Updates
2.9 Karyopharm Therapeutics
2.9.1 Karyopharm Therapeutics Details
2.9.2 Karyopharm Therapeutics Major Business
2.9.3 Karyopharm Therapeutics Multiple Myeloma Treatment Drugs Product and Services
2.9.4 Karyopharm Therapeutics Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Karyopharm Therapeutics Recent Developments/Updates
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Multiple Myeloma Treatment Drugs Product and Services
2.10.4 Teva Multiple Myeloma Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Teva Recent Developments/Updates
3.1 Global Multiple Myeloma Treatment Drugs Sales Quantity by Manufacturer (2020-2025)
3.2 Global Multiple Myeloma Treatment Drugs Revenue by Manufacturer (2020-2025)
3.3 Global Multiple Myeloma Treatment Drugs Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Multiple Myeloma Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Multiple Myeloma Treatment Drugs Manufacturer Market Share in 2024
3.4.3 Top 6 Multiple Myeloma Treatment Drugs Manufacturer Market Share in 2024
3.5 Multiple Myeloma Treatment Drugs Market: Overall Company Footprint Analysis
3.5.1 Multiple Myeloma Treatment Drugs Market: Region Footprint
3.5.2 Multiple Myeloma Treatment Drugs Market: Company Product Type Footprint
3.5.3 Multiple Myeloma Treatment Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Multiple Myeloma Treatment Drugs Market Size by Region
4.1.1 Global Multiple Myeloma Treatment Drugs Sales Quantity by Region (2020-2031)
4.1.2 Global Multiple Myeloma Treatment Drugs Consumption Value by Region (2020-2031)
4.1.3 Global Multiple Myeloma Treatment Drugs Average Price by Region (2020-2031)
4.2 North America Multiple Myeloma Treatment Drugs Consumption Value (2020-2031)
4.3 Europe Multiple Myeloma Treatment Drugs Consumption Value (2020-2031)
4.4 Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value (2020-2031)
4.5 South America Multiple Myeloma Treatment Drugs Consumption Value (2020-2031)
4.6 Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value (2020-2031)
5.1 Global Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
5.2 Global Multiple Myeloma Treatment Drugs Consumption Value by Type (2020-2031)
5.3 Global Multiple Myeloma Treatment Drugs Average Price by Type (2020-2031)
6.1 Global Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
6.2 Global Multiple Myeloma Treatment Drugs Consumption Value by Application (2020-2031)
6.3 Global Multiple Myeloma Treatment Drugs Average Price by Application (2020-2031)
7.1 North America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
7.2 North America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
7.3 North America Multiple Myeloma Treatment Drugs Market Size by Country
7.3.1 North America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2031)
7.3.2 North America Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
8.2 Europe Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
8.3 Europe Multiple Myeloma Treatment Drugs Market Size by Country
8.3.1 Europe Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2031)
8.3.2 Europe Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Multiple Myeloma Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
10.2 South America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
10.3 South America Multiple Myeloma Treatment Drugs Market Size by Country
10.3.1 South America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2031)
10.3.2 South America Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Multiple Myeloma Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Multiple Myeloma Treatment Drugs Market Drivers
12.2 Multiple Myeloma Treatment Drugs Market Restraints
12.3 Multiple Myeloma Treatment Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Multiple Myeloma Treatment Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Multiple Myeloma Treatment Drugs
13.3 Multiple Myeloma Treatment Drugs Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Multiple Myeloma Treatment Drugs Typical Distributors
14.3 Multiple Myeloma Treatment Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables Table 1. Global Multiple Myeloma Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031 Table 2. Global Multiple Myeloma Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Table 3. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors Table 4. Bristol Myers Squibb Major Business Table 5. Bristol Myers Squibb Multiple Myeloma Treatment Drugs Product and Services Table 6. Bristol Myers Squibb Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 7. Bristol Myers Squibb Recent Developments/Updates Table 8. Takeda Basic Information, Manufacturing Base and Competitors Table 9. Takeda Major Business Table 10. Takeda Multiple Myeloma Treatment Drugs Product and Services Table 11. Takeda Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 12. Takeda Recent Developments/Updates Table 13. Amgen Basic Information, Manufacturing Base and Competitors Table 14. Amgen Major Business Table 15. Amgen Multiple Myeloma Treatment Drugs Product and Services Table 16. Amgen Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 17. Amgen Recent Developments/Updates Table 18. Sanofi Basic Information, Manufacturing Base and Competitors Table 19. Sanofi Major Business Table 20. Sanofi Multiple Myeloma Treatment Drugs Product and Services Table 21. Sanofi Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 22. Sanofi Recent Developments/Updates Table 23. Merck Basic Information, Manufacturing Base and Competitors Table 24. Merck Major Business Table 25. Merck Multiple Myeloma Treatment Drugs Product and Services Table 26. Merck Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 27. Merck Recent Developments/Updates Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table 29. Johnson & Johnson Major Business Table 30. Johnson & Johnson Multiple Myeloma Treatment Drugs Product and Services Table 31. Johnson & Johnson Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 32. Johnson & Johnson Recent Developments/Updates Table 33. Novartis Basic Information, Manufacturing Base and Competitors Table 34. Novartis Major Business Table 35. Novartis Multiple Myeloma Treatment Drugs Product and Services Table 36. Novartis Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 37. Novartis Recent Developments/Updates Table 38. AbbVie Basic Information, Manufacturing Base and Competitors Table 39. AbbVie Major Business Table 40. AbbVie Multiple Myeloma Treatment Drugs Product and Services Table 41. AbbVie Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 42. AbbVie Recent Developments/Updates Table 43. Karyopharm Therapeutics Basic Information, Manufacturing Base and Competitors Table 44. Karyopharm Therapeutics Major Business Table 45. Karyopharm Therapeutics Multiple Myeloma Treatment Drugs Product and Services Table 46. Karyopharm Therapeutics Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 47. Karyopharm Therapeutics Recent Developments/Updates Table 48. Teva Basic Information, Manufacturing Base and Competitors Table 49. Teva Major Business Table 50. Teva Multiple Myeloma Treatment Drugs Product and Services Table 51. Teva Multiple Myeloma Treatment Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 52. Teva Recent Developments/Updates Table 53. Global Multiple Myeloma Treatment Drugs Sales Quantity by Manufacturer (2020-2025) & (K Dose) Table 54. Global Multiple Myeloma Treatment Drugs Revenue by Manufacturer (2020-2025) & (USD Million) Table 55. Global Multiple Myeloma Treatment Drugs Average Price by Manufacturer (2020-2025) & (US$/Dose) Table 56. Market Position of Manufacturers in Multiple Myeloma Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024 Table 57. Head Office and Multiple Myeloma Treatment Drugs Production Site of Key Manufacturer Table 58. Multiple Myeloma Treatment Drugs Market: Company Product Type Footprint Table 59. Multiple Myeloma Treatment Drugs Market: Company Product Application Footprint Table 60. Multiple Myeloma Treatment Drugs New Market Entrants and Barriers to Market Entry Table 61. Multiple Myeloma Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations Table 62. Global Multiple Myeloma Treatment Drugs Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR Table 63. Global Multiple Myeloma Treatment Drugs Sales Quantity by Region (2020-2025) & (K Dose) Table 64. Global Multiple Myeloma Treatment Drugs Sales Quantity by Region (2026-2031) & (K Dose) Table 65. Global Multiple Myeloma Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million) Table 66. Global Multiple Myeloma Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million) Table 67. Global Multiple Myeloma Treatment Drugs Average Price by Region (2020-2025) & (US$/Dose) Table 68. Global Multiple Myeloma Treatment Drugs Average Price by Region (2026-2031) & (US$/Dose) Table 69. Global Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 70. Global Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 71. Global Multiple Myeloma Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million) Table 72. Global Multiple Myeloma Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million) Table 73. Global Multiple Myeloma Treatment Drugs Average Price by Type (2020-2025) & (US$/Dose) Table 74. Global Multiple Myeloma Treatment Drugs Average Price by Type (2026-2031) & (US$/Dose) Table 75. Global Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 76. Global Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 77. Global Multiple Myeloma Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million) Table 78. Global Multiple Myeloma Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million) Table 79. Global Multiple Myeloma Treatment Drugs Average Price by Application (2020-2025) & (US$/Dose) Table 80. Global Multiple Myeloma Treatment Drugs Average Price by Application (2026-2031) & (US$/Dose) Table 81. North America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 82. North America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 83. North America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 84. North America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 85. North America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2025) & (K Dose) Table 86. North America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2026-2031) & (K Dose) Table 87. North America Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million) Table 88. North America Multiple Myeloma Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million) Table 89. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 90. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 91. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 92. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 93. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2025) & (K Dose) Table 94. Europe Multiple Myeloma Treatment Drugs Sales Quantity by Country (2026-2031) & (K Dose) Table 95. Europe Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million) Table 96. Europe Multiple Myeloma Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million) Table 97. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 98. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 99. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 100. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 101. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Region (2020-2025) & (K Dose) Table 102. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity by Region (2026-2031) & (K Dose) Table 103. Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million) Table 104. Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million) Table 105. South America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 106. South America Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 107. South America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 108. South America Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 109. South America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2025) & (K Dose) Table 110. South America Multiple Myeloma Treatment Drugs Sales Quantity by Country (2026-2031) & (K Dose) Table 111. South America Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million) Table 112. South America Multiple Myeloma Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million) Table 113. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Type (2020-2025) & (K Dose) Table 114. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Type (2026-2031) & (K Dose) Table 115. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Application (2020-2025) & (K Dose) Table 116. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Application (2026-2031) & (K Dose) Table 117. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Country (2020-2025) & (K Dose) Table 118. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity by Country (2026-2031) & (K Dose) Table 119. Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million) Table 120. Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million) Table 121. Multiple Myeloma Treatment Drugs Raw Material Table 122. Key Manufacturers of Multiple Myeloma Treatment Drugs Raw Materials Table 123. Multiple Myeloma Treatment Drugs Typical Distributors Table 124. Multiple Myeloma Treatment Drugs Typical Customers List of Figures Figure 1. Multiple Myeloma Treatment Drugs Picture Figure 2. Global Multiple Myeloma Treatment Drugs Revenue by Type, (USD Million), 2020 & 2024 & 2031 Figure 3. Global Multiple Myeloma Treatment Drugs Revenue Market Share by Type in 2024 Figure 4. Immunomodulatory drugs (IMiDs) Examples Figure 5. Proteasome inhibitors (PIs) Examples Figure 6. Monoclonal antibodies (mAbs) Examples Figure 7. Chimeric Antigen Receptor T-cell therapy (CAR-T therapy) Examples Figure 8. Histone deacetylase inhibitors (HDAC inhibitors) Examples Figure 9. Others Examples Figure 10. Global Multiple Myeloma Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Figure 11. Global Multiple Myeloma Treatment Drugs Revenue Market Share by Application in 2024 Figure 12. Hospital Examples Figure 13. Clinic Examples Figure 14. Global Multiple Myeloma Treatment Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031 Figure 15. Global Multiple Myeloma Treatment Drugs Consumption Value and Forecast (2020-2031) & (USD Million) Figure 16. Global Multiple Myeloma Treatment Drugs Sales Quantity (2020-2031) & (K Dose) Figure 17. Global Multiple Myeloma Treatment Drugs Price (2020-2031) & (US$/Dose) Figure 18. Global Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Manufacturer in 2024 Figure 19. Global Multiple Myeloma Treatment Drugs Revenue Market Share by Manufacturer in 2024 Figure 20. Producer Shipments of Multiple Myeloma Treatment Drugs by Manufacturer Sales ($MM) and Market Share (%): 2024 Figure 21. Top 3 Multiple Myeloma Treatment Drugs Manufacturer (Revenue) Market Share in 2024 Figure 22. Top 6 Multiple Myeloma Treatment Drugs Manufacturer (Revenue) Market Share in 2024 Figure 23. Global Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Region (2020-2031) Figure 24. Global Multiple Myeloma Treatment Drugs Consumption Value Market Share by Region (2020-2031) Figure 25. North America Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 26. Europe Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 27. Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 28. South America Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 29. Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 30. Global Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 31. Global Multiple Myeloma Treatment Drugs Consumption Value Market Share by Type (2020-2031) Figure 32. Global Multiple Myeloma Treatment Drugs Average Price by Type (2020-2031) & (US$/Dose) Figure 33. Global Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 34. Global Multiple Myeloma Treatment Drugs Revenue Market Share by Application (2020-2031) Figure 35. Global Multiple Myeloma Treatment Drugs Average Price by Application (2020-2031) & (US$/Dose) Figure 36. North America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 37. North America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 38. North America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Country (2020-2031) Figure 39. North America Multiple Myeloma Treatment Drugs Consumption Value Market Share by Country (2020-2031) Figure 40. United States Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 41. Canada Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 42. Mexico Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 43. Europe Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 44. Europe Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 45. Europe Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Country (2020-2031) Figure 46. Europe Multiple Myeloma Treatment Drugs Consumption Value Market Share by Country (2020-2031) Figure 47. Germany Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 48. France Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 49. United Kingdom Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 50. Russia Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 51. Italy Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 52. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 53. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 54. Asia-Pacific Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Region (2020-2031) Figure 55. Asia-Pacific Multiple Myeloma Treatment Drugs Consumption Value Market Share by Region (2020-2031) Figure 56. China Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 57. Japan Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 58. South Korea Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 59. India Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 60. Southeast Asia Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 61. Australia Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 62. South America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 63. South America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 64. South America Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Country (2020-2031) Figure 65. South America Multiple Myeloma Treatment Drugs Consumption Value Market Share by Country (2020-2031) Figure 66. Brazil Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 67. Argentina Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 68. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Type (2020-2031) Figure 69. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Application (2020-2031) Figure 70. Middle East & Africa Multiple Myeloma Treatment Drugs Sales Quantity Market Share by Country (2020-2031) Figure 71. Middle East & Africa Multiple Myeloma Treatment Drugs Consumption Value Market Share by Country (2020-2031) Figure 72. Turkey Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 73. Egypt Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 74. Saudi Arabia Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 75. South Africa Multiple Myeloma Treatment Drugs Consumption Value (2020-2031) & (USD Million) Figure 76. Multiple Myeloma Treatment Drugs Market Drivers Figure 77. Multiple Myeloma Treatment Drugs Market Restraints Figure 78. Multiple Myeloma Treatment Drugs Market Trends Figure 79. Porters Five Forces Analysis Figure 80. Manufacturing Cost Structure Analysis of Multiple Myeloma Treatment Drugs in 2024 Figure 81. Manufacturing Process Analysis of Multiple Myeloma Treatment Drugs Figure 82. Multiple Myeloma Treatment Drugs Industrial Chain Figure 83. Sales Channel: Direct to End-User vs Distributors Figure 84. Direct Channel Pros & Cons Figure 85. Indirect Channel Pros & Cons Figure 86. Methodology Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bristol Myers Squibb Takeda Amgen Sanofi Merck Johnson & Johnson Novartis AbbVie Karyopharm Therapeutics Teva
13 Oct 2025
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>
